![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 879507-25-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | NRC-AN-019 REF: 3D-EKB50725CAS: 879507-25-2 | Min. 95% | A consultar | Lun 26 Ago 24 |
![]() | AN-019 REF: TM-T26625CAS: 879507-25-2 | 98.01% | 274,00 €~2.336,00 € | Mar 03 Sep 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
NRC-AN-019
CAS:879507-25-2
NRC-AN-019 is an imatinib-resistant drug that belongs to the class of bcr-abl inhibitors. It has …
Fórmula:
C25H17F6N5O
Pureza:
Min. 95%
Peso molecular:
517.4 g/mol
Ref: 3D-EKB50725
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 26 de Agosto de 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
AN-019
CAS:879507-25-2
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic …
Fórmula:
C25H17F6N5O
Pureza:
98.01%
Forma y color:
Solid
Peso molecular:
517.43
Ref: TM-T26625
1mg | 274,00 € | ||
5mg | 675,00 € | ||
10mg | 923,00 € | ||
25mg | 1.421,00 € | ||
50mg | 1.850,00 € | ||
100mg | 2.336,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Septiembre de 2024